Commentary on Oeckl et al., "Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181".
作者信息
Head Elizabeth, Zetterberg Henrik
机构信息
Department of Pathology & Laboratory Medicine, University of California, Irvine, California, USA.
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
出版信息
Ann Neurol. 2022 Jul;92(1):3-5. doi: 10.1002/ana.26414. Epub 2022 Jun 2.
Abstract
摘要
相似文献
1
Commentary on Oeckl et al., "Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181".对奥克尔等人所著《唐氏综合征患者血清β-突触核蛋白水平更高且早于pTau181升高》的评论
Ann Neurol. 2022 Jul;92(1):3-5. doi: 10.1002/ana.26414. Epub 2022 Jun 2.
2
Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.血清β-突触核蛋白在唐氏综合征中升高，并先于 pTau181 的升高。
Ann Neurol. 2022 Jul;92(1):6-10. doi: 10.1002/ana.26360. Epub 2022 Apr 12.
3
Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.针对α-突触核蛋白的抗体在许多患有阿尔茨海默病的唐氏综合征患者大脑中检测到路易小体。
Ann Neurol. 1999 Mar;45(3):353-7. doi: 10.1002/1531-8249(199903)45:3<353::aid-ana11>3.0.co;2-4.
4
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease.β-突触核蛋白作为阿尔茨海默病突触退化的候选血液生物标志物。
Alzheimers Res Ther. 2022 Nov 30;14(1):179. doi: 10.1186/s13195-022-01125-1.
5
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.载脂蛋白 E ɛ4 等位基因与唐氏综合征成人阿尔茨海默病的临床和多模态生物标志物变化的关联。
JAMA Neurol. 2021 Aug 1;78(8):937-947. doi: 10.1001/jamaneurol.2021.1893.
6
Getting in charge of β-synuclein fibrillation.掌控β-突触核蛋白的纤维化过程。
J Biol Chem. 2017 Sep 29;292(39):16380-16381. doi: 10.1074/jbc.H117.780528.
7
[Role of genetics in the etiology of synucleinopathies].[遗传学在突触核蛋白病病因学中的作用]
Rev Esp Geriatr Gerontol. 2011 Oct;46 Suppl 1:3-11. doi: 10.1016/j.regg.2011.10.002.
8
Relationship of serum beta-synuclein with blood biomarkers and brain atrophy.血清β-突触核蛋白与血液生物标志物及脑萎缩的关系。
Alzheimers Dement. 2023 Apr;19(4):1358-1371. doi: 10.1002/alz.12790. Epub 2022 Sep 21.
9
Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies.通过多反应监测对脑脊液中α-、β-和γ-突触核蛋白进行定量分析显示，阿尔茨海默病和克雅氏病患者脑脊液中这些蛋白的浓度升高，但在突触核蛋白病患者中未发现改变。
Mol Cell Proteomics. 2016 Oct;15(10):3126-3138. doi: 10.1074/mcp.M116.059915. Epub 2016 Aug 9.
10
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.脑脊液中的β-突触核蛋白作为阿尔茨海默病的早期诊断标志物。
J Neurol Neurosurg Psychiatry. 2021 Apr;92(4):349-356. doi: 10.1136/jnnp-2020-324306. Epub 2020 Dec 30.
本文引用的文献
1
Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study.唐氏综合征中的皮质萎缩以及淀粉样蛋白和tau蛋白沉积：一项纵向研究。
Alzheimers Dement (Amst). 2022 Apr 1;14(1):e12288. doi: 10.1002/dad2.12288. eCollection 2022.
2
Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.血清β-突触核蛋白在唐氏综合征中升高，并先于 pTau181 的升高。
Ann Neurol. 2022 Jul;92(1):6-10. doi: 10.1002/ana.26360. Epub 2022 Apr 12.
3
Patterns of Mixed Pathologies in Down Syndrome.唐氏综合征的混合病理模式。
J Alzheimers Dis. 2022;87(2):595-607. doi: 10.3233/JAD-215675.
4
Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.基于生物流体的阿尔茨海默病相关病理生物标志物：文献综述与更新。
Alzheimers Dement. 2022 Sep;18(9):1687-1693. doi: 10.1002/alz.12618. Epub 2022 Feb 25.
5
Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.唐氏综合征患者中与年龄相关的阿尔茨海默病神经退行性变和神经元丢失的发育缺陷和动态分期。
Acta Neuropathol Commun. 2022 Jan 4;10(1):2. doi: 10.1186/s40478-021-01300-9.
6
Alzheimer's disease associated with Down syndrome: a genetic form of dementia.唐氏综合征相关的阿尔茨海默病：一种遗传性痴呆。
Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.
7
Blood Biomarkers for Alzheimer's Disease in Down Syndrome.唐氏综合征中阿尔茨海默病的血液生物标志物
J Clin Med. 2021 Aug 17;10(16):3639. doi: 10.3390/jcm10163639.
8
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.唐氏综合征成人血浆神经丝轻链浓度的诊断和预后性能及纵向变化：一项队列研究。
Lancet Neurol. 2021 Aug;20(8):605-614. doi: 10.1016/S1474-4422(21)00129-0.
9
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome.血浆中磷酸化 tau181 作为唐氏综合征成人阿尔茨海默病的潜在生物标志物。
Nat Commun. 2021 Jul 14;12(1):4304. doi: 10.1038/s41467-021-24319-x.
10
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.唐氏综合征成人阿尔茨海默病痴呆和轻度认知障碍的血浆总 tau 和神经丝轻链作为诊断生物标志物。
J Alzheimers Dis. 2021;79(2):671-681. doi: 10.3233/JAD-201167.
Zotero 插件